Diabetic foot ulcer (DFU) is the most typical and expensive sequela of diabetes mellitus, usually resulting in lower-extremity amputation with poor 5-year survival charges. Staphylococcus aureus is probably the most prevalent pathogen remoted from DFU, suggesting adaptation of S. aureus to the distinctive metabolic situations of diabetes.

Diabetes is a fancy metabolic dysfunction with will increase not solely in serum glucose ranges but in addition in ranges of different sugars, together with fructose, mannose, and glucose-6-phosphate (G6P). Nevertheless, the impact of metabolism of those sugars on the pathogenesis of S. aureus just isn’t totally understood.

On this research, we demonstrated that metabolism of G6P, fructose, and mannose induced larger expression of staphylococcal virulence components than did glucose metabolism, however solely G6P results had been impartial of glucose-mediated carbon catabolite repression, suggesting a physiologically related position in diabetes.

Our in vivo research additional demonstrated that G6P was extremely current in pores and skin adipose tissues of diabetic TALLYHO/JngJ mice, and subcutaneous an infection with S. aureus brought about considerably larger tissue necrosis and bacterial burden, in comparison with nondiabetic SWR/J mice.

Lastly, enhanced pathogenesis of S. aureus in diabetic TALLYHO/JngJ mice was considerably attenuated by deletion of the hexose phosphate transport (HPT) system. These outcomes recommend that G6P is a vital metabolic sign for S. aureus, enhancing the virulence in diabetes. A greater understanding of how G6P metabolism is linked to the virulence of S. aureus will result in the event of novel different therapeutics.

Sugars are important vitamins for S. aureus to outlive and proliferate inside the host. As a result of elevated serum glucose ranges are an indicator of diabetes, most research have targeted on the impact of glucose metabolism, and little or no is thought relating to the consequences of metabolism of different sugars on the pathogenesis of S. aureus in diabetes.

On this research, we demonstrated that G6P, which is very current in diabetes, can induce expression of staphylococcal virulence components that trigger extreme tissue necrosis and bacterial burden in pores and skin infections.

Our outcomes spotlight the significance of dietary management of blood sugar ranges, not solely glucose but in addition different extremely metabolizable sugars similar to G6P. A greater understanding of how activation of the HPT system is linked to the virulence of S. aureus will information growth of novel different therapeutics.

Elements Influencing Change in Serum Uric Acid after Administration of the Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin in Sufferers With Kind 2 Diabetes Mellitus

Though sodium-glucose cotransporter 2 (SGLT2) inhibitors decrease serum uric acid, their long-term impact on uric acid metabolism just isn’t properly understood. We analyzed pooled information from research whereby sufferers with sort 2 diabetes mellitus (T2DM) acquired luseogliflozin-an SGLT2 inhibitor.

Upon stratifying sufferers by baseline glycated hemoglobin (HbA1c) or serum uric acid, decrease HbA1c or larger serum uric acid stage was related to a larger discount in serum uric acid after remedy.

At week 12 of remedy, a major enhance in urinary glucose/creatinine (Cr) ratio and urinary uric acid clearance/Cr clearance ratio (CUA /CCr ratio) and a major discount in serum uric acid had been noticed.

Comparability of the subgroups of sufferers with a discount or a rise in serum uric acid confirmed that the rise subgroup had a better estimated glomerular filtration price (eGFR) at baseline, and the eGFR was considerably lowered, related to a major discount within the CUA /CCr ratio.

A number of regression evaluation confirmed that the discount in serum uric acid within the luseogliflozin group was strongly related to baseline excessive serum uric acid, low HbA1c ranges, and a rise in eGFR. Luseogliflozin was proven to scale back serum uric acid by enhancing urinary uric acid excretion in affiliation with elevated urinary glucose.

Therapy with luseogliflozin resulted in elevated serum uric acid in some sufferers, which can be as a result of lowered glomerular filtration of uric acid by way of the tubuloglomerular suggestions. SGLT2 inhibitors lowered serum uric acid desirably in sufferers with T2DM with low HbA1c and excessive serum uric acid. This text is protected by copyright. All rights reserved.

Steroid profiling and genetic variants in Chinese language ladies with gestational diabetes mellitus

Earlier research have demonstrated that steroids had been related to gestational diabetes mellitus (GDM). Nevertheless, outcomes from completely different research remained inconsistent, and solely a restricted vary of steroids had been investigated in these research.

Subsequently, we aimed to investigate complete steroid profiling in Chinese language ladies with GDM throughout third-trimester being pregnant. In 97 Chinese language pregnant ladies, we measured steroid profile utilizing a LC-MS/MS technique, and calculated product-to-precursor ratios in metabolic pathways of steroids.

Then sixteen genetic variants of genes encoding steroidogenic enzymes had been genotyped by MassARRAY system. There have been vital variations (P < 0.05) and apparent modifications (fold change <0.67 or >1.5) in steroids (testosterone, estriol, pregnenolone and dehydroepiandrosterone) and product-to-precursor ratios (E2/T and T/AD) between GDM and management teams.

Hepatic insulin resistance (HIR) is taken into account to be an impartial predictor of metabolic problems and performs an necessary position in systemic irritation, which contributes to abnormalities in heart problems (CVD) threat components.

The purpose of this research was to research the connection between HIR and new markers of cardiovascular dangers, together with leptin/adiponectin ratio (L/A), lipoprotein(a) [Lp(a)], and tumor necrosis issue alpha (TNF-α), at comparable entire physique insulin sensitivity in non-diabetic people with or with out CVD and at excessive threat of growing sort 2 diabetes.

Diabetes (Type 1) Exosome RNA
P241-DB1 - Ask for price

Diabetes (Type 2) Exosome RNA
P241-DB2 - Ask for price

Lung Diabetic Disease Lysate
XBL-10362 0.1 mg
EUR 796.2
Description: Human lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lung tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Total RNA - Diabetic Disease: Colon
R1236090Dia-50 50 ug
EUR 421.2

Colon Diabetic Disease Lysate
XBL-10333 0.1 mg
EUR 796.2
Description: Human colon tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human colon tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the colon tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The colon tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Ileum Diabetic Disease Lysate
XBL-10379 0.1 mg
EUR 796.2
Description: Human small intestine: Ileum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Ileum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Ileum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Ileum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Total RNA - Diabetic Disease: Stomach
R1236248Dia-50 50 ug
EUR 421.2

Jejunum Diabetic Disease Lysate
XBL-10381 0.1 mg
EUR 796.2
Description: Human small intestine: Jejunum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Jejunum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Jejunum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Jejunum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Stomach Diabetic Disease Lysate
XBL-10387 0.1 mg
EUR 796.2
Description: Human stomach tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human stomach tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the stomach tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The stomach tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Total RNA - Diabetic Disease: Pancreas
R1236188Dia-50 50 ug
EUR 421.2

Duodenum Diabetic Disease Lysate
XBL-10336 0.1 mg
EUR 796.2
Description: Human duodenum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human duodenum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the duodenum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The duodenum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Total RNA - Diabetic Disease: Esophagus
R1236106Dia-50 50 ug
EUR 421.2

Esophagus Diabetic Disease Lysate
XBL-10338 0.1 mg
EUR 796.2
Description: Human esophagus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human esophagus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the esophagus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The esophagus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Pancrease Diabetic Disease Lysate
XBL-10371 0.1 mg
EUR 796.2
Description: Human pancrease tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human pancrease tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the pancrease tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The pancrease tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

cDNA - Human Diabetic Diseased Tissue: Lung
C1236152Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Skin
C1236218Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Brain
C1236035Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Colon
C1236090Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Heart
C1236122Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Liver
C1236149Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Whole Eye
C1236108Dia-10 10 reactions
EUR 393

cDNA - Human Diabetic Diseased Tissue: Kidney
C1236142Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Spleen
C1236246Dia 40 reactions
EUR 729

Skeletal Muscle Diabetic Disease Lysate
XBL-10369 0.1 mg
EUR 796.2
Description: human skeletal muscle tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human skeletal muscle tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the Skeletal Muscle tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The Skeletal Muscle tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

cDNA - Human Diabetic Diseased Tissue: Lymph Node
C1236161Dia-10 10 reactions
EUR 393

cDNA - Human Diabetic Diseased Tissue: Stomach
C1236248Dia 40 reactions
EUR 729

cDNA - Human Diabetic Diseased Tissue: Bone Marrow
C1236024Dia-10 10 reactions
EUR 420

cDNA - Human Diabetic Diseased Tissue: Pancreas
C1236188Dia 40 reactions
EUR 729

Pancreas Membrane Diabetic Disease Lysate
XBL-10785 0.1 mg
EUR 752.1
Description: Human pancreas tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human pancreas tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated pancreas tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated pancreas tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

cDNA - Human Diabetic Diseased Tissue: Esophagus
C1236106Dia 40 reactions
EUR 729

Membrane Protein - Diabetic Disease: Pancreas
P3236188Dia 0.1 mg
EUR 410

Total Protein - Human Diabetic Diseased Tissue: Lung
P1236152Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Skin
P1236218Dia 1 mg
EUR 471

Adipose Subcutaneous Diabetic Disease Lysate
20-105 0.1 mg
EUR 1508.1
Description: Human subcutaneous adipose tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human subcutaneous adipose tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the subcutaneous adipose tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The subcutaneous adipose tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Total Protein - Human Diabetic Diseased Tissue: Brain
P1236035Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Colon
P1236090Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Heart
P1236122Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Liver
P1236149Dia 1 mg
EUR 471

cDNA - Human Diabetic Diseased Tissue: Skeletal Muscle
C1236171Dia 40 reactions
EUR 729

Total Protein - Human Diabetic Diseased Tissue: Whole Eye
P1236108Dia 1 mg
EUR 1147

Total Protein - Human Diabetic Diseased Tissue: Kidney
P1236142Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Spleen
P1236246Dia 1 mg
EUR 471

Skeletal Muscle Membrane Diabetic Disease Lysate
XBL-10855 0.1 mg
EUR 752.1
Description: human skeletal muscle tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human skeletal muscle tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated Skeletal Muscle tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated Skeletal Muscle tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

cDNA - Human Diabetic Diseased Tissue: Visceral Adipose
C1236003VisDia-10 10 reactions
EUR 420

Membrane Protein - Diabetic Disease: Skeletal Muscle
P3236171Dia 0.1 mg
EUR 410

Total Protein - Human Diabetic Diseased Tissue: Adrenal
P1236004Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Stomach
P1236248Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Bone Marrow
P1236024Dia 1 mg
EUR 1147

Total Protein - Human Diabetic Diseased Tissue: Pancreas
P1236188Dia 1 mg
EUR 471

Frozen Tissue Section - Human Diabetic Diseased Tissue: Eye
T1236108Dia 5 slides
EUR 662

cDNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum
C1236227Dia 40 reactions
EUR 729

Total Protein - Human Diabetic Diseased Tissue: Esophagus
P1236106Dia 1 mg
EUR 471

Frozen Tissue Section - Human Diabetic Diseased Tissue: Lung
T1236152Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Skin
T1236218Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Brain
T1236035Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Colon
T1236090Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Heart
T1236122Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Liver
T1236149Dia 5 slides
EUR 475

cDNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose
C1236003SubDia-10 10 reactions
EUR 420

cDNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum
C1236230Dia 40 reactions
EUR 729

Genomic DNA - Human Diabetic Diseased Tissue: Lung, from a single donor
D1236152Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Skin, from a single donor
D1236218Dia 50 ug
EUR 489

Frozen Tissue Section - Human Diabetic Diseased Tissue: Kidney
T1236142Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Spleen
T1236246Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Lung
T2236152Dia 5 slides
EUR 238

cDNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum
C1236101Dia 40 reactions
EUR 729

Genomic DNA - Human Diabetic Diseased Tissue: Colon, from a single donor
D1236090Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Heart, from a single donor
D1236122Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Liver, from a single donor
D1236149Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Brain, from a single donor
D1236035Dia 50 ug
EUR 489

Total Protein - Human Diabetic Diseased Tissue: Skeletal Muscle
P1236171Dia 1 mg
EUR 471

Frozen Tissue Section - Human Diabetic Diseased Tissue: Adrenal
T1236004Dia 5 slides
EUR 475

Frozen Tissue Section - Human Diabetic Diseased Tissue: Stomach
T1236248Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Colon
T2236090Dia 5 slides
EUR 238

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Liver
T2236149Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Whole Eye, from a single donor
D1236108Dia 50 ug
EUR 1152

Genomic DNA - Human Diabetic Diseased Tissue: Kidney, from a single donor
D1236142Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Spleen, from a single donor
D1236246Dia 50 ug
EUR 489

Total Protein - Human Diabetic Diseased Tissue: Visceral Adipose
P1236003VisDia 1 mg
EUR 1147

Frozen Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow
T1236024Dia 5 slides
EUR 662

Frozen Tissue Section - Human Diabetic Diseased Tissue: Pancreas
T1236188Dia 5 slides
EUR 475

Genomic DNA - Human Diabetic Diseased Tissue: Stomach, from a single donor
D1236248Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Adrenal, from a single donor
D1236004Dia 50 ug
EUR 489

Frozen Tissue Section - Human Diabetic Diseased Tissue: Esophagus
T1236106Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Stomach
T2236248Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Esophagus, from a single donor
D1236106Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Pancreas, from a single donor
D1236188Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Bone Marrow, from a single donor
D1236024Dia 50 ug
EUR 1152

Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Ileum
P1236227Dia 1 mg
EUR 471

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow
T2236024Dia 5 slides
EUR 238

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Esophagus
T2236106Dia 5 slides
EUR 238

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Pancreas
T2236188Dia 5 slides
EUR 238

Total Protein - Human Diabetic Diseased Tissue: Subcutaneous Adipose
P1236003SubDia 1 mg
EUR 1147

Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Duodenum
P1236101Dia 1 mg
EUR 471

Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Jejunum
P1236230Dia 1 mg
EUR 471

Frozen Tissue Section - Human Diabetic Diseased Tissue: Visceral Adipose
T1236003VisDia 5 slides
EUR 662

Frozen Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle
T1236171Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Parathyroid
T2236189Dia 5 slides
EUR 629

Genomic DNA - Human Diabetic Diseased Tissue: Skeletal Muscle, from a single donor
D1236171Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Visceral Adipose, from a single donor
D1236003VisDia 50 ug
EUR 1152

Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum
T1236227Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle
T2236171Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum, from a single donor
D1236227Dia 50 ug
EUR 489

Frozen Tissue Section - Human Diabetic Diseased Tissue: Subcutaneous Adipose
T1236003SubDia 5 slides
EUR 662

Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum
T1236230Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum
T2236227Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum, from a single donor
D1236230Dia 50 ug
EUR 489

Genomic DNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose, from a single donor
D1236003SubDia 50 ug
EUR 1152

Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum
T1236101Dia 5 slides
EUR 475

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum
T2236230Dia 5 slides
EUR 238

Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum, from a single donor
D1236101Dia 50 ug
EUR 489

Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum
T2236101Dia 5 slides
EUR 238

Canine C Peptide(C Peptide) ELISA Kit
ECA0028 96T
EUR 681.12
Description: Method of detection: Coated with Antigen, Competitive ELISA;Reacts with: Canine;Sensitivity: 0.469 ng/ml

DIABLO Blocking Peptide
33R-5520 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DIABLO antibody, catalog no. 20R-1288

DIABLO Blocking Peptide
DF7017-BP 1mg
EUR 234

Smac/DIABLO Blocking Peptide
3298BP-50 each
EUR 183.6

C Peptide 1 ELISA kit
55R-IB79101 96 wells
EUR 745.2
Description: ELISA kit for the detection of C Peptide 1 in the research laboratory

Rat C peptide ELISA kit
E02C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat C peptide ELISA kit
E02C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat C peptide ELISA kit
E02C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog C peptide ELISA kit
E08C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog C peptide ELISA kit
E08C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog C peptide ELISA kit
E08C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig C peptide ELISA kit
E07C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig C peptide ELISA kit
E07C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig C peptide ELISA kit
E07C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat C- Peptide ELISA Kit
ELA-E0447r 96 Tests
EUR 1063.2

Goat C peptide ELISA kit
E06C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Goat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat C peptide ELISA kit
E06C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Goat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat C peptide ELISA kit
E06C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Goat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human C peptide ELISA kit
E01C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human C peptide ELISA kit
E01C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human C peptide ELISA kit
E01C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse C peptide ELISA kit
E03C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse C peptide ELISA kit
E03C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse C peptide ELISA kit
E03C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Mouse C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse C- Peptide ELISA Kit
ELA-E0447m 96 Tests
EUR 1038

Rabbit C peptide ELISA kit
E04C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rabbit C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit C peptide ELISA kit
E04C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rabbit C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit C peptide ELISA kit
E04C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rabbit C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey C peptide ELISA kit
E09C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Monkey C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey C peptide ELISA kit
E09C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Monkey C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey C peptide ELISA kit
E09C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Monkey C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Canine C- Peptide ELISA Kit
ELA-E0447d 96 Tests
EUR 1113.6

Monkey C- Peptide ELISA Kit
ELA-E0447Mo 96 Tests
EUR 1113.6

Porcine C- Peptide ELISA Kit
ELA-E0447p 96 Tests
EUR 1113.6

Rat C- Peptide, connecting peptide ELISA Kit
CELI-66099r 96 Tests
EUR 1063.2

Human C- Peptide, connecting peptide ELISA Kit
CELI-66099h 96 Tests
EUR 988.8

Mouse C- Peptide, connecting peptide ELISA Kit
CELI-66099m 96 Tests
EUR 1038

Bovine C- Peptide, connecting peptide ELISA Kit
CELI-66099b 96 Tests
EUR 1113.6

Canine C- Peptide, connecting peptide ELISA Kit
CELI-66099d 96 Tests
EUR 1113.6

Rabbit C- Peptide, connecting peptide ELISA Kit
CELI-66099Rb 96 Tests
EUR 1113.6

Chicken C- Peptide, connecting peptide ELISA Kit
CELI-66099c 96 Tests
EUR 1113.6

General C- Peptide, connecting peptide ELISA Kit
CELI-66099Ge 96 Tests
EUR 1063.2

Porcine C- Peptide, connecting peptide ELISA Kit
CELI-66099p 96 Tests
EUR 1113.6

Guinea pig C peptide ELISA kit
E05C0042-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Guinea pig C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig C peptide ELISA kit
E05C0042-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Guinea pig C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig C peptide ELISA kit
E05C0042-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Guinea pig C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Procollagen C peptidase ELISA kit
E02P0624-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Procollagen C peptidase ELISA kit
E02P0624-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Procollagen C peptidase ELISA kit
E02P0624-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Procollagen C peptidase ELISA kit
E08P0624-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Procollagen C peptidase ELISA kit
E08P0624-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Procollagen C peptidase ELISA kit
E08P0624-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Procollagen C peptidase ELISA kit
E07P0624-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Procollagen C peptidase ELISA kit
E07P0624-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

We searched Medline, Embase, the Cochrane Library, and gray literature sources as much as August 2021 for randomized managed trials (RCTs) that in contrast sotagliflozin with placebo or different antidiabetic brokers in sufferers with sort 2 diabetes. Our main final result was change in HbA1c from baseline.

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here